BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22002306)

  • 21. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
    Wu D; Asiedu M; Wei Q
    Oncogene; 2009 Jun; 28(22):2219-30. PubMed ID: 19421144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central role of the exchange factor GEF-H1 in TNF-α-induced sequential activation of Rac, ADAM17/TACE, and RhoA in tubular epithelial cells.
    Waheed F; Dan Q; Amoozadeh Y; Zhang Y; Tanimura S; Speight P; Kapus A; Szászi K
    Mol Biol Cell; 2013 Apr; 24(7):1068-82. PubMed ID: 23389627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular signal-regulated kinase regulates RhoA activation and tumor cell plasticity by inhibiting guanine exchange factor H1 activity.
    von Thun A; Preisinger C; Rath O; Schwarz JP; Ward C; Monsefi N; Rodríguez J; Garcia-Munoz A; Birtwistle M; Bienvenut W; Anderson KI; Kolch W; von Kriegsheim A
    Mol Cell Biol; 2013 Nov; 33(22):4526-37. PubMed ID: 24043311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases.
    Birkenfeld J; Nalbant P; Bohl BP; Pertz O; Hahn KM; Bokoch GM
    Dev Cell; 2007 May; 12(5):699-712. PubMed ID: 17488622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microtubules regulate GEF-H1 in response to extracellular matrix stiffness.
    Heck JN; Ponik SM; Garcia-Mendoza MG; Pehlke CA; Inman DR; Eliceiri KW; Keely PJ
    Mol Biol Cell; 2012 Jul; 23(13):2583-92. PubMed ID: 22593214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RhoA regulators Myo9b and GEF-H1 are targets of cyclic nucleotide-dependent kinases in platelets.
    Comer S; Nagy Z; Bolado A; von Kriegsheim A; Gambaryan S; Walter U; Pagel O; Zahedi RP; Jurk K; Smolenski A
    J Thromb Haemost; 2020 Nov; 18(11):3002-3012. PubMed ID: 32692911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GEF-H1/RhoA signaling pathway mediates pro-inflammatory effects of NF-κB on CD40L-induced pulmonary endothelial cells.
    Chang M; Yi L; Zhou Z; Yi X; Chen H; Liang X; Jin R; Huang X
    Mol Immunol; 2023 May; 157():42-52. PubMed ID: 36989839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition.
    Aijaz S; D'Atri F; Citi S; Balda MS; Matter K
    Dev Cell; 2005 May; 8(5):777-86. PubMed ID: 15866167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells.
    Mizuarai S; Yamanaka K; Kotani H
    Cancer Res; 2006 Jun; 66(12):6319-26. PubMed ID: 16778209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing GEF-H1 Expression Inhibits Renal Cyst Formation, Inflammation, and Fibrosis via RhoA Signaling in Nephronophthisis.
    Hu Q; Lai J; Chen H; Cai Y; Yue Z; Lin H; Sun L
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1.
    Murakami M; Meneses PI; Knight JS; Lan K; Kaul R; Verma SC; Robertson ES
    Int J Cancer; 2008 Aug; 123(3):500-10. PubMed ID: 18470881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
    Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
    J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatiotemporal dynamics of GEF-H1 activation controlled by microtubule- and Src-mediated pathways.
    Azoitei ML; Noh J; Marston DJ; Roudot P; Marshall CB; Daugird TA; Lisanza SL; Sandí MJ; Ikura M; Sondek J; Rottapel R; Hahn KM; Danuser G
    J Cell Biol; 2019 Sep; 218(9):3077-3097. PubMed ID: 31420453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Y-box factor ZONAB/DbpA associates with GEF-H1/Lfc and mediates Rho-stimulated transcription.
    Nie M; Aijaz S; Leefa Chong San IV; Balda MS; Matter K
    EMBO Rep; 2009 Oct; 10(10):1125-31. PubMed ID: 19730435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of p114-RhoGEF and Lfc in Wnt-3a- and dishevelled-induced RhoA activation and neurite retraction in N1E-115 mouse neuroblastoma cells.
    Tsuji T; Ohta Y; Kanno Y; Hirose K; Ohashi K; Mizuno K
    Mol Biol Cell; 2010 Oct; 21(20):3590-600. PubMed ID: 20810787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton.
    Krendel M; Zenke FT; Bokoch GM
    Nat Cell Biol; 2002 Apr; 4(4):294-301. PubMed ID: 11912491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.
    Shen CH; Chen HY; Lin MS; Li FY; Chang CC; Kuo ML; Settleman J; Chen RH
    Cancer Res; 2008 Oct; 68(19):7779-87. PubMed ID: 18829532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.
    Dan Q; Shi Y; Rabani R; Venugopal S; Xiao J; Anwer S; Ding M; Speight P; Pan W; Alexander RT; Kapus A; Szászi K
    J Biol Chem; 2019 Oct; 294(42):15446-15465. PubMed ID: 31481470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2F1 induces pituitary tumor transforming gene (PTTG1) expression in human pituitary tumors.
    Zhou C; Wawrowsky K; Bannykh S; Gutman S; Melmed S
    Mol Endocrinol; 2009 Dec; 23(12):2000-12. PubMed ID: 19837943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of gef-h1, a guanine nucleotide exchange factor for RhoA, by DNA transfection.
    Brecht M; Steenvoorden AC; Collard JG; Luf S; Erz D; Bartram CR; Janssen JW
    Int J Cancer; 2005 Feb; 113(4):533-40. PubMed ID: 15455375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.